In this issue:
- SLNB alone for cervical cancer
- ICIs for recurrent cervical cancer in previously irradiated field
- Adjuvant chemoradiotherapy vs radiotherapy for high-risk endometrial cancer
- QoL with dostarlimab for endometrial cancer
- PARP inhibitor maintenance after chemotherapy in advanced epithelial ovarian cancer
- Olaparib in BRCA-mutated platinum-sensitive ovarian cancer
- Multidisciplinary ambulatory management of malignant bowel obstruction
- SBRT for oligometastatic parenchymal lesions in ovarian cancer
- Clinical significance of B7-H4 expression in ovarian cancer
- Radiotherapy experiences in granulosa cell tumour of the ovary
Please login below to download this issue (PDF)